Navigation Links
Could Fertility Drugs Make Kids Shorter?

By Barbara Bronson Gray
HealthDay Reporter

SATURDAY, June 23 (HealthDay News) -- For those who need help getting pregnant, the thought of having a child who's a little shorter than other kids probably won't be much of a worry. But the question of whether infertility treatment causes unanticipated consequences remains fertile ground for researchers.

In a study scheduled for presentation Saturday at the Endocrine Society annual meeting in Houston, researchers found full-term children conceived with fertility drugs were about one inch shorter than their peers.

The researchers wanted to find out whether there was a difference in height among children whose mothers used only ovarian stimulation by fertility drugs such as Clomid (clomiphene) without in-vitro fertilization (IVF).

Children conceived with the help of ovarian stimulation alone account for about 5 percent of all births in the developed world, according to the researchers.

Previous studies have suggested that children conceived by IVF may be taller than naturally conceived kids. The researchers wanted to know if something in the process of IVF, which includes fertilization and culture of embryos in a laboratory dish, could affect stature. So they studied children conceived without IVF, but with the assistance of fertility drugs that cause ovulation.

"The challenge in doing research like this is that in general the people who come to infertility clinics have been trying to get pregnant for multiple years," said Dr. Valerie Baker, medical director at the Stanford Fertility and Reproductive Medical Center, in Palo Alto, Calif. "These people often have serious medical problems. So it's possible that the issue is not the fertility treatment, but something going on with people who have been trying to get pregnant for more than a year without success," she said. Baker was not involved in the study.

The researchers, led by Dr. Tim Savage, a pediatrician and research fellow at the Liggins Institute, University of Auckland, in New Zealand, studied 84 children conceived with the help of fertility drugs and 258 who were conceived naturally. All were between 3 and 10 years old and from a single-fetus, full-term pregnancy. None had low birth weight, a factor that can be associated with health problems.

The children conceived with the help of fertility drugs were nearly an inch shorter than the others, although still within the normal range, even with differences in their parents' height taken into account. Parental height is considered the key factor in determining a child's height.

The height difference was greater in boys, who were more than an inch shorter on average than naturally conceived boys.

There was no significant difference in general physical health between the two groups of children.

The authors speculated that the height difference may be due to something that happens around the point of conception. They suggested it could be caused by "imprinting" variations -- changes in the way genes are expressed, which could be related to the process of ovarian stimulation. The appropriate expression of genes is important in normal development.

Other experts greeted the study findings with caution.

Dr. Edward Illions, an associate professor of obstetrics and gynecology at Albert Einstein College of Medicine and a reproductive endocrinologist at Montefiore Institute for Reproductive Medicine in Hartsdale, N.Y., said any number of mechanisms, including the act of stimulation, could affect imprinting.

Illions also expressed concern with the study's limitations. "The researchers don't tell us which particular drugs the women were on, what stimulation protocols were used or the number of treatment cycles rendered to these patients," he said.

Dr. David Cohen, chief of reproductive endocrinology and infertility at the University of Chicago, said researchers need to continue studying children born with infertility technology to better understand any implications of fertility treatment. "As far as this study goes, there are no take-aways," he said.

Data and conclusions of research presented at medical meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Library of Medicine sheds light on female infertility.

SOURCES: Valerie Baker, M.D., medical director, Stanford Fertility and Reproductive Medical Center, Palo Alto, Calif.; Edward Illions, M.D., associate professor, obstetrics and gynecology at Albert Einstein College of Medicine and reproductive endocrinologist, Montefiore Institute for Reproductive Medicine, Hartsdale, N.Y.; David Cohen, M.D., chief, reproductive endocrinology and infertility, University of Chicago, Chicago; June 23, 2012, news release and presentation, Endocrine Society, annual meeting, Houston, Texas

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The Affordable Care Act could have negative consequences for elderly recipients
2. Blood test for pregnant women could predict risk of having dangerously small babies
3. Could Sunlight Lower Your Odds for Pancreatic Cancer?
4. Could Psoriasis Increase Odds for Type 2 Diabetes?
5. Cheaper drug could lead to serious eye issues
6. Control gene for conveyor belt cells could help improve oral vaccines, treat intestinal disease
7. Mouse Study Suggests Certain Fats Could Trigger Crohns, Colitis
8. Noisy Wards Could Threaten Hospital Patients Health
9. 2-1-1 could be effective tool in fighting cancer disparities
10. Could Bloodletting Ease Heart Risks for the Obese?
11. Diabetes drug could be a promising therapy for traumatic brain injury
Post Your Comments:
Related Image:
Could  Fertility Drugs Make Kids Shorter?
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... has prided itself for not only fulfilling the needs of advisers and clients ... an affordable price and providing top-tier customer service. However, there's always room for ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
Breaking Medicine Technology: